The US Food and Drug Administration has approved an expanded label for Amgen and Wyeth’s biologic drug, Enbrel (etanercept), with the firms now able to market the product to improve physical function ...

Amgen has already paid $762 million to wrap up off-label marketing claims with the feds. Now, 48 states have won another promise to pay from the California-based drugmaker. This time, it's $71 million ...

Immunex Corp. could hear from the Food and Drug Administration as early as today whether its star drug, Enbrel, already approved to treat rheumatoid arthritis, also will be approved for psoriatic ...

Right now, Novartis' ($NVS) Sandoz has the only biosimilar on the U.S. market. And it's looking to make it two. On Friday, the company announced that the FDA had ...

The medication she took to slow the disease, a powerful chemotherapy drug called methotrexate, left her nauseated and tired. It was painful to walk and to hug her two children. Then she started taking ...

Enbrel (etanercept) is a prescription drug used to treat certain inflammatory conditions. This drug can interact with certain medications and vaccines. For example, Enbrel can interact with infliximab ...

Novartis’ Sandoz unit has become the first company to win approval in the US for a biosimilar version of Amgen’s big-selling TNF inhibitor Enbrel. Sandoz’s drug – called Erelzi – has been approved for ...

THOUSAND OAKS, Calif., November 12, 2006 -- Amgen (NASDAQ: AMGN) today announced that Enbrel? (etanercept) is the first biologic with published data to show improvements in multiple measures of ...

VIRGINIA BEACH, Va. (CN) – A man claims Amgen’s arthritis drug Enbrel gave him cancer, and that Amgen and its affiliates hid the extent of the drug’s side effects from doctors and their patients.

NEW YORK (Reuters) - Amgen Inc and Wyeth on Monday said their Enbrel arthritis drug will now carry a prominent black box warning on its package insert label in the United States, citing risks of ...

THOUSAND OAKS, Calif., and RADNOR, Penn., – New data from multiple studies evaluating the use of ENBREL® (etanercept), the only fully human TNF receptor, in patients with long-standing disease, as ...

Immunex Corp. got the green light to begin marketing its rheumatoid arthritis drug, Enbrel, as a treatment for psoriatic arthritis, opening the door for the Seattle biotech to begin building a ...